Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oligomaltose is a type of oligosaccharide, a carbohydrate composed of a few saccharide units. In the context of the provided clinical trial, it is an active ingredient in a skin care ointment being studied for its efficacy in controlling eczema pruritus. While the exact chemical structure of "oligomaltose" can vary, it is often related to isomaltooligosaccharides (IMOs), which are glucose oligomers with α-D-(1,6)-linkages. Oligosaccharides, particularly those with prebiotic properties, are known to interact with the skin microbiome, promoting the growth of beneficial bacteria and inhibiting pathogenic ones. This modulation of the microbiome contributes to improved skin barrier function, reduced inflammation, and overall skin health. Beyond topical applications, IMOs are also widely used as dietary supplements and functional food ingredients due to their prebiotic effects on gut health, low glycemic index, and anti-caries properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oligomaltose.